908 Devices Inc (MASS) FinancialsMASS908 Devices Inc

908 Devices Inc (MASS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Device sales revenue, accounting for 62.9% of total sales, equivalent to $7.41M. Other significant revenue streams include Consumables and service revenue and License and contract revenue. Understanding this composition is critical for investors evaluating how MASS navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, 908 Devices Inc maintains a gross margin of 51.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -79.69%, while the net margin is -74.00%. These profitability ratios, combined with a Return on Equity (ROE) of -25.02%, provide a clear picture of how effectively MASS converts its operational activities into shareholder value.

In the context of the broader market, MASS competes directly with industry leaders such as DRTS and INCR. With a market capitalization of $440.99M, it holds a significant position in the sector. When comparing efficiency, MASS's gross margin of 51.90% stands against DRTS's N/A and INCR's 0.34%. Such benchmarking helps identify whether 908 Devices Inc is trading at a premium or discount relative to its financial performance.

The company reported a 23% revenue growth in Q2 2026, reaching $16.1 million, and has a gross margin of 51.90% in the same quarter, showcasing strong operational efficiency despite recent net income losses.